[1]
|
Craig, T.J., et al. (2005) How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? The Journal of Allergy and Clinical Immunology, 116, 1264-1266. doi:10.1016/j.jaci.2005.10.009
|
[2]
|
Kiely, J.L., et al. (2004) Intranasal corticosteroid therapy for obstructive sleep apnea in patients with coexisting rinitis. Thorax, 59, 50-55.
|
[3]
|
Kerr, P., et al. (1992) The importance of nasal resistance in Obstructive Sleep Apnea Syndrome. Journal of Otolaryngology, 21, 189-195.
|
[4]
|
McLean, H.A., et al. (2005) Effect of treating nasal obstruction on the severity of obstructive sleep apnoea. European Respiratory Journal, 25, 521-527.
doi:10.1183/09031936.05.00045004
|
[5]
|
DeFronzo, R.A., (2009) From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58, 773-795.
doi:10.2337/db09-9028
|
[6]
|
Knitson, K.L., et al. (2007) The metabolic consequences of sleep deprivation. Sleep Medicine Reviews, 11, 163-178.
|
[7]
|
Spiegel, K., et al. (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of International Medicine, 141, 846-850.
|
[8]
|
Siegel, A., et al. (1999) Impact of sleep debt on metabolic and endocrine function. Lancet, 354, 1435-1439.
doi:10.1016/S0140-6736(99)01376-8
|
[9]
|
Widén, E.I.M., et al. (1998) The relationship between first-phase insulin secretion and glucose metabolism. Acta Endocrinology, 127, 289-293.
|
[10]
|
Cappuccio, F.P., et al. (2010) Quantity and quality of sleep and incidence of type 2 diabetes. Diabetes Care, 33, 414-420. doi:10.2337/dc09-1124
|
[11]
|
NaJib, A.T., et al. (2003) A prospective study of self reported sleep duration and incident diabetes in women. Diabetes Care, 26, 380-384. doi:10.2337/diacare.26.2.380
|
[12]
|
Tasali, E., et al. (2008) Slow-wave sleep and the risk of type 2 diabetes in humans. Proceedings of the National Academy of Sciences of the USA, 105, 1044-1049.
|
[13]
|
Vgonitzas, A.N., et al. (2009) Insomnia with objective short seep duration is associated with type 2 diabetes. Diabetes Care, 32, 1980-1985. doi:10.2337/dc09-0284
|
[14]
|
Bitz, C., et al. (2005) A paradoxical diurnal movement pattern in obese subjects with type 2 diabetes. Diabetes Care, 28, 2040-2042. doi:10.2337/diacare.28.8.2040
|
[15]
|
Tiihonene, M., et al. (1993) The severity of obstructive sleep apnoea is associated with insulin resistance. Journal of Sleep Research, 2, 56-61.
doi:10.1111/j.1365-2869.1993.tb00062.x
|
[16]
|
Bergman, R.N. (1989) Toward physiological understanding of glucose tolerance: Minimal model approach. Diabetes, 38, 1512-1527. doi:10.2337/diabetes.38.12.1512
|
[17]
|
Punjabi, N.M., et al. (2009) Alterations in glucose disposal in sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine, 179, 235-240.
|
[18]
|
Punjabi, N.M., et al. (2002) Sleep disordered breathing and insulin resi stance in middle-aged and overweight men. American Journal of Respiratory and Critical Care Medicine, 165, 562-563.
|
[19]
|
Mallon, L., et al. (2005) High incidence of diabetes in men with sleep complaints or short sleep duration. Diabetes Care, 28, 2762-2767.
doi:10.2337/diacare.28.11.2762
|
[20]
|
Seicean, S., et al. (2008) Sleep disordered breathing and impaired glucose metabolism in normal weight and overweight/obese individuals. Diabetes Care, 31, 1001-1006. doi:10.2337/dc07-2003
|
[21]
|
Aronsohn, R.S., et al. (2010) Impact of untreated Obstructive Sleep Apnoea on Glucose control in Type 2 Diabetes. American Journal of Respiratory and Critical Care Medicine, 181, 507-513.
doi:10.1164/rccm.200909-1423OC
|
[22]
|
Muraki, I., et al. (2010) Nocturnal intermittent hypoxia and the development of type 2 diabetes: The circulatory risks in communities study. Diabetologia, 53, 481-488.
doi:10.1007/s00125-009-1616-0
|
[23]
|
The Action to Control Cardiovascular Risk in Diabetes Study Group. (2008) Effect of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine, 358, 2545-2549. doi:10.1056/NEJMoa0802743
|
[24]
|
McNicholas, A. and Bonsignore, M.R. (2010) Sleep apnea. European Respiratory Society Monograph, 50, 360-380.
|
[25]
|
Kent, B.D., et al. (2011) Obstructive sleep apnea and inflammation: Relationship to cardiovascular co-morbidity. Respiratory Physiology and Neurobiology, 178, 475-481.
doi:10.1016/j.resp.2011.03.015
|
[26]
|
Taylor, R.S., et al. (2009) Systemic inflammation: A key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnea syndrome? Thorax, 64, 631-636.
|
[27]
|
Ip, M.S., et al. (2000) Clinical investigations serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 118, 580-586.
|
[28]
|
McArdle, M., et al. (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: A matched controlled study. American Journal of Respiratory and Critical Care Medicine, 175, 190-195.
|
[29]
|
Wang. C.J., et al. (2010) Cytokines in the progression of pancreatic B-cell dysfunction. International Journal of Endocrinology, 2010, Article ID 515136
doi:10.1155/2010/515136
|
[30]
|
Kolb, H. (2010) The global diabetes epidemic is a consequence of lifestyle induced low grade inflammation. Diabetologia, 53, 10-20. doi:10.1007/s00125-009-1573-7
|
[31]
|
Smith, R., et al. (2002) What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest, 121, 164-172. doi:10.1378/chest.121.1.164
|
[32]
|
Phillips, B.G., et al. (1999) Recent weight gain in patients with newly diagnosed obstructive sleep apnea. Journal of hypertension, 17, 1297-1300.
doi:10.1097/00004872-199917090-00009
|
[33]
|
Tatti, P. and Barber, A. (2011) Human Obesity: An overview of the mechanisms and the basis for treatment Advances in Medicine and Biology, 15, 341-352.
|
[34]
|
Spiegel, K., et al. (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of International Medicine, 141, 846-850.
|
[35]
|
Newman, A.B., et al. (2005) Progression and regression of sleep-disordered breathing with changes in weight: The sleep hearth health study. Archives of International Medicine, 165, 2408-2413.
doi:10.1001/archinte.165.20.2408
|
[36]
|
Luboshitzky, B., et al. (2002) Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. The Journal of Clinical Endocrinology and Metabolism, 87, 3394.
|
[37]
|
Grunstein, R.R., et al. (1989) Neuroendocrine dysfunction in sleep apnea: Reversal by continuous positive airways pressure therapy. The Journal of Clinical Endocrinology and Metabolism, 68, 352-358.
doi:10.1210/jcem-68-2-352
|
[38]
|
Santamaria, J.D., et al. (1988) Reversible reproductive dysfunction in men with obstructive sleep apnoea. Clinical Endocrinology, 28, 461-470.
doi:10.1111/j.1365-2265.1988.tb03680.x
|
[39]
|
Luboshitzky, R., et al. (2001) Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. The Journal of Clinical Endocrinology and Metabolism, 86, 1134-1139. doi:10.1210/jc.86.3.1134
|
[40]
|
Ando, S., Rubens, R., et al. (1984) Androgen plasma levels in male diabetics. Journal of Endocrinological Investigation, 7, 21-24.
|
[41]
|
Haffner, S.M., et al. (1994) Insulin resistance, body fat distribution and sex hormones in men. Diabetes, 43, 212-219. doi:10.2337/diabetes.43.2.212
|
[42]
|
Vermeulen, A., et al. (1999) Testosterone, body composition and aging. Journal of Clinical Investigation, 22, 110-116.
|
[43]
|
Pasquali, R., et al. (1991) Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism, 40, 101-104. doi:10.1016/0026-0495(91)90199-7
|
[44]
|
Tatti, P., et al. (2001) Leptin levels in diabetic and nondiabetic subjects. Endocrine, 15, 305-308.
|
[45]
|
Harsh, I.A., et al. (2003) Leptin and grelin levels in patients with sleep apnea: Effect of CPAP treatment. European Respiratory Journal, 22, 251-257.
doi:10.1183/09031936.03.00010103
|
[46]
|
Brander, P.E., et al. (1999) Effect of obesity and erect/ supine posture on lateral cephalometry: Relationship to sleep-disordered breathing. European Respiratory Journal, 13, 398-402. doi:10.1183/09031936.99.13239899
|
[47]
|
Hoffstein, V., et al. (1984) Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. American Review Respiratory Disease, 130, 175-178.
|
[48]
|
Horner, R.L., et al. (1989) Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea. Quarterly Journal of Medicine, 72, 719-735.
|
[49]
|
Brown, L.K. (2002) A waist is a terrible thing to mind: Central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest, 122, 774-778.
doi:10.1378/chest.122.3.774
|
[50]
|
Fong, S.Y., et al. (2005) Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome. Journal of Psychosomatic Respiratory, 58, 55-60.
doi:10.1016/j.jpsychores.2004.05.004
|
[51]
|
Guilleminault, C., et al. (1988) Determinants of daytime sleepiness in obstructive sleep apnea. Chest, 94, 32-37.
doi:10.1378/chest.94.1.32
|
[52]
|
Seneviratne, U. and Puvanendran, K. (2004) Excessive daytime sleepiness in obstructive sleep apnea: Prevalence, severity, and predictors. Sleep Medicine, 5, 339-343.
doi:10.1016/j.sleep.2004.01.021
|
[53]
|
Phillips, B.G., et al. (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. American Journal of Physiology Heart Circuit Physiology, 279, H234-H237
|
[54]
|
Ozturk, L., et al. (2003) The association of the severity of obstructive sleep apnea with plasma leptin levels. Archives of Otolaryngology Head and Neck Surgery, 129, 538-540. doi:10.1001/archotol.129.5.538
|
[55]
|
Keller, T., et al. (2007) Obstructive sleep apnea syndrome: The effect of diabetes and autonomic neuropathy. Journal of Physiology and Pharmacology, 58, 313-318.
|
[56]
|
Ficker, J.H., et al. (1998) Obstructive sleep apnoea and diabetes mellitus: The role of cardiovascular autonomic neuropathy. European Respiratory Journal, 11, 14-19.
doi:10.1183/09031936.98.11010014
|
[57]
|
Clarke, B.F., et al. (1979) Diabetic autonomic neuropathy. Diabetologia, 17, 195-212. doi:10.1007/BF01235856
|